6-32519641-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_002125.4(HLA-DRB5):c.381G>A(p.Lys127Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00096 ( 2 hom., cov: 3)
Exomes 𝑓: 0.00051 ( 14 hom. )
Consequence
HLA-DRB5
NM_002125.4 synonymous
NM_002125.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.63
Genes affected
HLA-DRB5 (HGNC:4953): (major histocompatibility complex, class II, DR beta 5) HLA-DRB5 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. There are multiple pseudogenes of this gene. [provided by RefSeq, Feb 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 6-32519641-C-T is Benign according to our data. Variant chr6-32519641-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2656452.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.63 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HLA-DRB5 | NM_002125.4 | c.381G>A | p.Lys127Lys | synonymous_variant | 3/6 | ENST00000374975.4 | NP_002116.2 | |
HLA-DRB5 | XM_011514562.3 | c.381G>A | p.Lys127Lys | synonymous_variant | 3/6 | XP_011512864.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HLA-DRB5 | ENST00000374975.4 | c.381G>A | p.Lys127Lys | synonymous_variant | 3/6 | 6 | NM_002125.4 | ENSP00000364114.3 |
Frequencies
GnomAD3 genomes AF: 0.000936 AC: 39AN: 41672Hom.: 2 Cov.: 3
GnomAD3 genomes
AF:
AC:
39
AN:
41672
Hom.:
Cov.:
3
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000135 AC: 12AN: 88952Hom.: 4 AF XY: 0.0000818 AC XY: 4AN XY: 48918
GnomAD3 exomes
AF:
AC:
12
AN:
88952
Hom.:
AF XY:
AC XY:
4
AN XY:
48918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000511 AC: 310AN: 606672Hom.: 14 Cov.: 7 AF XY: 0.000511 AC XY: 158AN XY: 309496
GnomAD4 exome
AF:
AC:
310
AN:
606672
Hom.:
Cov.:
7
AF XY:
AC XY:
158
AN XY:
309496
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000959 AC: 40AN: 41698Hom.: 2 Cov.: 3 AF XY: 0.00112 AC XY: 23AN XY: 20518
GnomAD4 genome
AF:
AC:
40
AN:
41698
Hom.:
Cov.:
3
AF XY:
AC XY:
23
AN XY:
20518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | HLA-DRB5: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at